drugset
drugset / Trial / NCT03357289

Mix Vaccine for Metastatic Kidney Cancer

NCT03357289 ↗

Phase 1/2 Completed 30 enrolled Fuda Cancer Hospital, Guangzhou Jinan University Guangzhou · collab
RandomizedSingle-groupOpen-labelTreatment

Summary

The aim of this study is the safety and efficacy of mix vaccine to small metastases of kidney cancer.

Timeline

Start
2017-11-30
Primary completion
2018-11-30
Completion
2019-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Mix vaccine Vaccine 0.5 ml Subcutaneous

Indications

kidney cancer vaccinia